Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine
about
sameAs
Three-dimensional pharmacology, a subject ranging from ignorance to overstatements.Stereoselective biotransformation of ketamine in equine liver and lung microsomes.A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome.Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.The use of ketamine in complex regional pain syndrome: possible mechanisms.Chiral toxicology: it's the same thing...only different.Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug.Clinical and pharmacokinetic evaluation of S-ketamine for intravenous general anaesthesia in horses undergoing field castration.Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.Enantioselective pharmacokinetics of (R)- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome.Effect of rifampicin on S-ketamine and S-norketamine plasma concentrations in healthy volunteers after intravenous S-ketamine administrationSimultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.Ketamine for the treatment of chronic non-cancer pain.Advances in translational neuropathic research: example of enantioselective pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief in complex regional pain syndrome.Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing.S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children.Pharmacokinetic study in pigs and in vitro metabolic characterization in pig- and human-liver microsomes reveal marked differences in disposition and metabolism of tiletamine and zolazepam (Telazol).Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).Development of a method for analysis of ketamine and norketamine enantiomers in equine brain and cerebrospinal fluid by capillary electrophoresis.Influence of (S)-ketamine on human motor cortex excitability.Pharmacokinetics of S-ketamine during prolonged sedation at the pediatric intensive care unit.St John's wort greatly decreases the plasma concentrations of oral S-ketamine.Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department.Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers.Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
P2860
Q31027709-46C3651A-5C38-4214-857C-71646281140DQ33651967-3AF72C5B-90C3-45A4-AD6C-F1FA32EC84DEQ34166221-12803CD4-E63D-48C8-AEA2-A4673F3D4DF6Q34179516-F1A26049-D22B-49A1-BF2D-435BCFC7FB3AQ34182127-AB0731D0-00DB-4DF4-8915-8F7213552064Q34979115-C8B1E777-4C1D-4670-AC7E-08EB978AD77CQ34988290-11A4B228-1DA4-4E77-ACC9-AFB1583E6656Q35609867-2942586A-D549-41B7-82E9-6F7F2E2AF405Q36087811-D17CC3C2-181A-4F7C-AADD-B223643F023FQ36430033-FFCB5900-3745-4FBE-B0F7-15DC4B7B7994Q36578014-08B24521-AE63-4FAA-9A06-B68BBE576F50Q36779133-F3662118-AFD1-4E56-A45F-D7434763FF18Q37786623-DFE15ECC-B37D-48D9-8C3D-B724BB639B96Q37848196-2229E7E3-8F37-4D5B-B66B-DF798077DA5AQ38793772-65929032-0455-401C-86D1-D13D2B238165Q41338181-0435BF72-188F-4C87-9DCA-6CFB19212016Q45188486-13466D68-426D-4B88-8EC8-6DA3B84C3C7CQ45882350-51FACFDD-52F3-4C74-A48C-F99F775EA158Q45939966-1004B035-5B9E-4D50-8623-F810FB92E9A9Q47876511-8B927A63-5490-4E81-A80B-E3B75FC24938Q48112559-04F0F156-F08A-492D-B787-ECDAC78A1896Q48187100-CDCC018E-325E-4BE4-BF3D-213E7B416757Q48258575-C72C0C37-86A2-4B61-860B-C9E34E2B9C1BQ48591391-ECE4D036-88EC-4A08-A2DF-3CD01ABF7C22Q50324088-B0DC9CF3-BCE1-4490-910F-C0516B064286Q55438088-920C0ED4-EF17-424F-88AC-6BABD2BCF4D8
P2860
Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@ast
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@en
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@nl
type
label
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@ast
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@en
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@nl
prefLabel
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@ast
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@en
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@nl
P2093
P356
P1476
Stereoselective pharmacokineti ...... e elimination of S(+)-ketamine
@en
P2093
G Geisslinger
J Schüttler
P356
10.1067/MCP.2001.119722
P407
P577
2001-11-01T00:00:00Z